SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Melania memes are digital collectibles intended to function as an expression of support for and engagement with the values embodied by the symbol MELANIA

Melania Trump

Melania Trump is trending as users debate the legitimacy of the associated meme coin, with community members aggressively clashing over whether the project is a sophisticated grift or a viable asset. The discourse is heavily fueled by broader political polarization and skepticism surrounding the Trump family's various ventures in the cryptocurrency space.

Everspin Technologies, Inc. engages in the provision of magnetoresistive random access memory (MRAM) solutions. Its products include Toggle MRAM, Spin-transfer Torque MRAM, TMR Sensors, and Embedded MRAM. The company was founded by Saied Tehrani on May 16, 2008 and is headquartered in Chandler, AZ.

Everspin Technologies Inc

Everspin Technologies is currently generating significant investor buzz as the community weighs its role in space exploration and mission-critical defense hardware against recent volatility and technical pullbacks. Traders are closely monitoring a potential inclusion in the Russell 2000 Index while debating whether the stock's recent price action represents a temporary accumulation phase or a deeper correction.

WorldFinancial

WorldFinancial (WLFI) is trending as the community debates potential catalysts like upcoming banking charter approval and the impact of the Clarity Act on future price action. Investors are actively discussing the token's low float and locked supply, with bullish sentiment focused on a potential supply shock while critics label the project a risk.

MARA Holdings, Inc. is a digital asset technology company, which engages in mining cryptocurrencies with a focus on the Bitcoin ecosystem. It also deals with owning and operating bitcoin mining facilities or data centers, selling proprietary software or technology to third parties operating in the Bitcoin ecosystem, offering advisory and consulting services to support Bitcoin mining ventures in domestic and international jurisdictions, and generating electricity from renewable energy resources or methane gas capture to power Bitcoin mining projects. The company was founded on February 23, 2010 and is headquartered in Hallandale Beach, FL.

MARA Holdings Inc.

Marathon Digital Holdings Inc

Marathon Digital Holdings is currently trending as shareholders voice intense frustration over sustained underperformance and a lack of insider buying, with many comparing the company unfavorably to mining sector peers who have successfully secured large-scale AI infrastructure deals. The discussion is heavily centered on skepticism toward the CEO's leadership and strategic direction, as investors remain divided over the company's transition from Bitcoin mining to AI data center operations.

Freddie Mac engages in the provision of housing finance system solutions. It operates through the Single-Family and Multifamily segments. The Single-Family segment is involved in purchase, securitization, and guarantee of single-family loans, investments, and management of single-family mortgage credit risk and market risk. The Multifamily segment focuses on purchase, securitization, and guarantee of multifamily loans, investments, securities, and management of multifamily mortgage credit risk and market risk. The company was founded on July 24, 1970 and is headquartered in McLean, VA.

Federal Home Loan Mortgage Corp

Freddie Mac

Freddie Mac (FMCC) and Fannie Mae (FNMA) are trending as investors speculate on potential recapitalization and relisting of the GSEs, driven by high-profile endorsements from figures like Bill Ackman and Michael Burry. The community is actively discussing rumors surrounding executive orders, upcoming financial disclosures, and the administration's potential strategy to use an IPO as a catalyst for housing affordability and national financial policy.

Papa John's International, Inc. engages in the operation and franchise of pizza delivery and carryout restaurants. It operates through the following segments: Domestic Company-owned Restaurants, North America Franchising, North America Commissaries, International Operations, and All Others. The Domestic Company-Owned Restaurants segment consists of retail sales of pizza and side items, breadsticks, cheese sticks, chicken poppers and wings, dessert items, and canned and bottled beverages. The North America Franchising segment involves the offering of sales and support activities, development rights, and collection of royalties from franchisees located in the United States and Canada. The North America Commissaries segment includes the eleven full-service regional dough production and distribution and quality control centers. The International Operations segment represents all restaurant operations outside of the United States and Canada. The All Others segment focuses on franchise contributions to marketing funds and sale, company-owned and franchised restaurants, information systems and related services used in restaurant operations, point-of-sale system, online and other technology-based ordering platforms, printing, and promotional items. The company was founded by John H. Schnatter in 1984 and is headquartered in Louisville, KY.

Papa John`s International, Inc.

Papa John's (PZZA) is trending amid intense investor frustration over the board's rejection of buyout offers and a recent downgrade by S&P Global Ratings following poor operating performance. The community is actively debating the stock's potential as a short squeeze candidate, with many retail investors advocating for a hostile takeover to replace management as the company struggles with store closures and a suspended dividend.

Forte Biosciences, Inc. is a biopharmaceutical company, which engages in the provision of dermatology products and services. Its lead product includes FB-401, which is a live biotherapeutic for the treatment of inflammatory skin disease, including pediatric and adult patients with atopic dermatitis. The company was founded by Paul A. Wagner on May 3, 2017 and is headquartered in Dallas, TX.

Forte Biosciences Inc

Forte Biosciences is trending due to a definitive agreement for its acquisition by Argenx in an all-cash deal, a move that sparked significant momentum after the company's recent clinical milestones. The community is actively debating the implications of this exit for long-term shareholders while monitoring the stock's price action as it stabilizes near the acquisition offer level.

Summit Therapeutics, Inc. is a biopharmaceutical company, that focuses on the discovery, development, and commercialization of patient, physician, caregiver, and societal-friendly medicinal therapies intended to improve quality of life, increase potential duration of life, and resolve serious unmet medical needs. The firm conducts clinical programs focusing on Clostridioides Difficile Infection (CDI). Its lead product, Ridinilazole, is an orally administered small molecule antibiotic that is in Phase III clinical trials for the treatment of CDI. The company was founded in 2003 and is headquartered in Miami, FL.

Summit Therapeutics Inc

Summit Therapeutics is trending as investors react to encouraging phase 2 results for Ivonescimab in triple-negative breast cancer, fueling community optimism about the drug's expanding potential across multiple indications. Despite ongoing debates regarding data quality and trial design compared to established industry standards, shareholders are closely watching for further clinical validation as they look toward future regulatory milestones.

TG Therapeutics, Inc. engages in the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its product pipeline includes TG-1501, TG-1701, Ublituximab, and Umbralisib. The company was founded by Michael Sean Weiss and Laurence H. Shaw on May 18, 1993 and is headquartered in Morrisville, NC.

TG Therapeutics Inc

TG Therapeutics is seeing strong community interest driven by the growth of Briumvi and high anticipation for its subcutaneous formulation, which has fueled persistent buyout speculation. Investors are closely watching for updates on commercial execution and potential strategic interest from larger biopharma players in light of positive market share momentum.

Eton Pharmaceuticals, Inc. engages in the development, acquisition, and commercialization of prescription drug products. Its products include Biorphen, Alaway Preservative Free, zonisamide oral suspension, topiramate oral suspension, lamotrigine for oral suspension, cysteine injection, and ephedrine ready-to-use injection. The company was founded in April 2017 and is headquartered in Deer Park, IL.

Eton Pharmaceuticals Inc

Eton Pharmaceuticals is currently surging following a record-breaking second quarter that saw revenue nearly double year-over-year, prompting management to significantly raise full-year guidance. Investors are actively celebrating the company's commercial execution and strong earnings performance, with many in the community highlighting the stock's impressive trajectory following its transition to a high-growth, rare-disease-focused business.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 
